Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$8.62M Buy
139,416
+1,178
+0.9% +$74.1K 1.36% 19
2016
Q4
$8.66M Buy
138,238
+4,467
+3% +$273K 1.43% 19
2016
Q3
$8.44M Sell
133,771
-1,232
-0.9% -$79.8K 1.41% 18
2016
Q2
$8.36M Buy
135,003
+9,222
+7% +$562K 1.42% 17
2016
Q1
$7.18M Sell
125,781
-20,113
-14% -$1.12M 1.25% 23
2015
Q4
$8.64M Buy
145,894
+3,282
+2% +$189K 1.5% 16
2015
Q3
$7.76M Sell
142,612
-2,910
-2% -$189K 1.37% 19
2015
Q2
$9.78M Sell
145,522
-555
-0.4% -$36.2K 1.57% 17
2015
Q1
$8.55M Buy
146,077
+146
+0.1% +$8.82K 1.3% 20
2014
Q4
$9.55M Buy
145,931
+6,286
+5% +$396K 1.47% 16
2014
Q3
$8.07M Buy
139,645
+16,923
+14% +$940K 1.33% 20
2014
Q2
$6.93M Buy
122,722
+26,715
+28% +$1.4M 1.14% 32
2014
Q1
$4.93M Buy
96,007
+2,721
+3% +$138K 0.84% 50
2013
Q4
$4.93M Buy
93,286
+16,150
+21% +$794K 0.85% 50
2013
Q3
$3.45M Sell
77,136
-393
-0.5% -$17.4K 0.64% 61
2013
Q2
$3.21M Buy
+77,529
New +$3.39M 0.61% 65

Other funds holding ABBV

Beacon Trust's ABBV Position: Q1 2017 in Review

Beacon Trust increased its AbbVie (ABBV) stake by 0.85% in Q1 2017, buying an estimated $74.1K and bringing the position to 139,416 shares worth $8.62M. The position accounts for 1.36% of the portfolio, ranked #19.

Beacon Trust first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $9.78M in Q2 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Beacon Trust held 139,416 shares of AbbVie worth $8.62M as of Q1 2017.
  • Beacon Trust bought 1,178 AbbVie shares in Q1 2017, an estimated $74.1K.
  • AbbVie made up 1.36% of Beacon Trust's portfolio in Q1 2017, its #19 holding.
  • Beacon Trust first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
  • Beacon Trust's AbbVie position peaked at $9.78M in Q2 2015.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.